APA (7th ed.) Citation

Yulin Leng, Xiaoxu Fu, Lisen Qian, Qiqi Li, Hong Gao, Hongyan Xie, & Chunguang Xie. (2022). Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial protocol. BMC.

Chicago Style (17th ed.) Citation

Yulin Leng, Xiaoxu Fu, Lisen Qian, Qiqi Li, Hong Gao, Hongyan Xie, and Chunguang Xie. Efficacy, Safety and Therapeutic Mechanism of Shen-Qi Xiao-Tan Formula in the Treatment of Peripheral Atherosclerosis in Patients with Type 2 Diabetes Mellitus: A Randomized, Double-blind, Placebo-controlled Trial Protocol. BMC, 2022.

MLA (9th ed.) Citation

Yulin Leng, et al. Efficacy, Safety and Therapeutic Mechanism of Shen-Qi Xiao-Tan Formula in the Treatment of Peripheral Atherosclerosis in Patients with Type 2 Diabetes Mellitus: A Randomized, Double-blind, Placebo-controlled Trial Protocol. BMC, 2022.